Freshpet (FRPT) Tops Q3 EPS by 19c; offers outlook

Freshpet (NASDAQ: FRPT) reported Q3 EPS of $0.58, $0.19 better than the analyst estimate of $0.39. Revenue for the quarter came in at $317.8 million versus the consensus estimate of $309.76 million.

Outlook

For full year 2026, the Company is updating its guidance and now expects the following:

Net sales growth in the range of 12% to 13%, compared to growth of 10% to 12% in the previous guidance;
Adjusted EBITDA in the range of $215 million to $220 million, compared to $210 million to $220 million in the previous guidance; and
Positive Free Cash Flow with capital expenditures between $125 to $150 million, compared to ~$150 million in the previous guidance.

The Company is reiterating its long-term guidance. For full year 2027, the Company expects:

Net sales well in excess of the category growth rate, unchanged;
Adjusted Gross Margin of at least 49%, unchanged; and
Adjusted EBITDA margin in the range of 20% to 22%, unchanged.

For earnings history and earnings-related data on Freshpet (FRPT) click here.

You May Also Be Interested In

• Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
• FatPipe, Inc. (FATN) Reports Q3 EPS of $0.09
• Barclays Downgrades Expro Group (XPRO) to Equalweight